TIDMMERI
RNS Number : 2710W
Merian Chrysalis Investment Co. Ltd
16 April 2019
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS RESTRICTED AND
IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION IN THE UNITED
STATES OF AMERICA, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA
(OTHER THAN THE UNITED KINGDOM AND THE REPUBLIC OF IRELAND),
CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.
16 April 2019
Merian Chrysalis Investment Company Limited (the "Company")
Result of Placing under Placing Programme
Further to the announcement made by the Company on 26 March
2019, the Company today announces that it has successfully raised
gross proceeds of GBP100 million pursuant to the Placing. The Board
and the Investment Adviser are pleased with the strong response to
the Placing which will allow the Company to continue to invest in
the exciting opportunities within the pipeline sourced by the
Investment Adviser.
Accordingly, an aggregate of 90,909,091 new Ordinary Shares have
been issued and allotted conditionally upon admission at a price of
110 pence per share (the "Placing Price").
Applications have been made for the admission of 90,909,091 new
Ordinary Shares to listing on the premium listing segment of the
Official List and to trading on the Main Market of London Stock
Exchange Group plc ("Admission"). It is expected that Admission
will become effective and that dealings in the new Ordinary Shares
will commence at 8.00 a.m. on 18 April 2019.
Following Admission, the Company will have 190,909,091 Ordinary
Shares in issue. Therefore, the total number of voting rights of
the Company will be 190,909,091 and this figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest in, the Company.
Terms not defined in this announcement shall have the same
meaning as the defined terms in the announcement on 26 March
2019.
Richard Watts, Co-fund manager, commented:
"We are delighted by the level of demand from both existing and
new investors. The Chrysalis proposition is resonating strongly
with late-stage, private companies that are seeking new investors
as they look to evolve their shareholder base, as evidenced by our
ability to quickly deploy the initial Chrysalis launch
proceeds."
Nick Williamson, Co-fund manager, commented:
"The growing opportunity for crossover investing in the UK and
across Europe is compelling. Investors have recognised this and the
new funds that they have provided will allow us to continue to
pursue our exciting pipeline of opportunities."
For further information, please contact:
Merian Global Investors:
Will Gold +44 (0) 20 7332 7500
Liberum:
Gillian Martin / Christopher
Britton +44 (0) 20 3100 2222
Zeus Capital:
John Goold / Ben Robertson +44 (0) 20 3829 5000
Maitland Administration (Guernsey)
Limited:
Aimee Gontier / Elaine Smeja +44 (0) 1481 749364
A copy of the Prospectus is available for inspection at:
www.morningstar.co.uk/uk/nsm as well as on the Company's website at
www.merian.com/chrysalis.
A copy of this announcement will be available on the Company's
website at www.Merian.com/Chrysalis. Neither the content of the
Company's website, nor the content on any website accessible from
hyperlinks on its website for any other website, is incorporated
into, or forms part of, this announcement nor, unless previously
published by means of a recognised information service, should any
such content be relied upon in reaching a decision as to whether or
not to acquire, continue to hold, or dispose of, securities in the
Company.
Terms used but not defined in this announcement shall have the
meanings given to such terms in the Prospectus.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014. Upon the publication of
this announcement, this inside information is now considered to be
in the public domain.
LEI: 213800F9SQ753JQHSW24
Important Notice
This announcement has been issued by and is the sole
responsibility of the Company. Liberum Capital Limited ("Liberum")
and Zeus Capital Limited ("Zeus Capital"), each of which are
authorised and regulated by the Financial Conduct Authority in the
United Kingdom, are acting only for the Company in connection with
the matters described in this announcement and are not acting for
or advising any other person, or treating any other person as its
client, in relation thereto and will not be responsible for
providing the regulatory protection afforded to clients of each of
them or advice to any other person in relation to the matters
contained herein. Neither Liberum, Zeus Capital nor any of its or
their respective affiliates, directors, officers, employees,
advisers or agents accepts any responsibility or liability
whatsoever for this announcement, its contents or otherwise in
connection with it or any other information relating to the
Company, whether written, oral or in a visual or electronic
format.
This announcement may not be published, distributed or
transmitted by any means or media, directly or indirectly, in whole
or in part, in or into the United States. This announcement does
not constitute an offer to sell, or a solicitation of an offer to
buy, securities in the United States. The securities mentioned
herein have not been, and will not be, registered under the U.S.
Securities Act of 1933, as amended (the "US Securities Act") or
with any securities regulatory authority of any state or other
jurisdiction of the United States and will not be offered, sold,
exercised, resold, transferred or delivered, directly or
indirectly, in or into the United States or to, or for the account
or benefit of, any US person (as defined under Regulation S under
the US Securities Act). The Company has not been, and will not be,
registered under the U.S. Investment Company Act of 1940, as
amended.
Neither this announcement nor any copy of it may be: (i) taken
or transmitted into or distributed in any member state of the
European Economic Area (other than the United Kingdom and the
Republic of Ireland), Canada, Australia or the Republic of South
Africa or to any resident thereof, or (ii) taken or transmitted
into or distributed in Japan or to any resident thereof. Any
failure to comply with these restrictions may constitute a
violation of the securities laws or the laws of any such
jurisdiction. The distribution of this announcement in other
jurisdictions may be restricted by law and the persons into whose
possession this document comes should inform themselves about, and
observe any such restrictions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ROICKPDKDBKBOQD
(END) Dow Jones Newswires
April 16, 2019 02:01 ET (06:01 GMT)
Chrysalis Investments (LSE:CHRY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chrysalis Investments (LSE:CHRY)
Historical Stock Chart
From Jul 2023 to Jul 2024